iconEarnings Announcement After Market Close

Gilead Sciences Inc GILD:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 04/23/24 EDT
67.08UNCH (UNCH)
Volume
7,221,845
52 week range
65.90 - 87.86
Loading...
  • Open66.58
  • Day High67.18
  • Day Low66.36
  • Prev Close67.08
  • 52 Week High87.86
  • 52 Week High Date01/19/24
  • 52 Week Low65.90
  • 52 Week Low Date04/18/24

Key Stats

  • Market Cap83.647B
  • Shares Out1.25B
  • 10 Day Average Volume6.57M
  • Dividend3.08
  • Dividend Yield4.59%
  • Beta0.22
  • YTD % Change-17.2

KEY STATS

  • Open66.58
  • Day High67.18
  • Day Low66.36
  • Prev Close67.08
  • 52 Week High87.86
  • 52 Week High Date01/19/24
  • 52 Week Low65.90
  • 52 Week Low Date04/18/24
  • Market Cap83.647B
  • Shares Out1.25B
  • 10 Day Average Volume6.57M
  • Dividend3.08
  • Dividend Yield4.59%
  • Beta0.22
  • YTD % Change-17.2

RATIOS/PROFITABILITY

  • EPS (TTM)4.50
  • P/E (TTM)14.89
  • Fwd P/E (NTM)16.95
  • EBITDA (TTM)11.506B
  • ROE (TTM)25.70%
  • Revenue (TTM)27.116B
  • Gross Margin (TTM)76.04%
  • Net Margin (TTM)20.69%
  • Debt To Equity (MRQ)109.43%

EVENTS

  • Earnings Date04/25/2024
  • Ex Div Date03/14/2024
  • Div Amount0.77
  • Split Date-
  • Split Factor-

Latest On Gilead Sciences Inc

Profile

MORE
Gilead Sciences, Inc. is a biopharmaceutical company. It is engaged in advancing medicines to prevent and treat life-threatening diseases, including human immunodeficiency virus (HIV), viral hepatitis, coronavirus disease 2019 (COVID-19) and cancer. It is focused on the discovery, development and commercialization of medicines in areas of unmet medical need. Its portfolio of marketed products includes AmBisome, Atripla, Biktarvy, Cayston, Complera, Descovy, Descovy for PrEP...
Daniel O'Day
Chairman of the Board, Chief Executive Officer
Andrew Dickinson
Chief Financial Officer
Deborah Telman
Executive Vice President - Corporate Affairs, General Counsel
Address
333 LAKESIDE DR
Foster City, CA
94404
United States

Top Peers

SYMBOLLASTCHG%CHG
GSK
GSK plc
40.86UNCHUNCH
BMY
Bristol-Myers Squibb Co
48.86UNCHUNCH
VRTX
Vertex Pharmaceuticals Inc
400.76UNCHUNCH
ZTS
Zoetis Inc
150.88UNCHUNCH
AMGN
Amgen Inc
273.01UNCHUNCH